To cite this paper use one of the standards below:
Extracellular vesicles (EVs) release by Trypanosoma cruzi trypomastigotes modulate host-parasite interactions and disease outcomes across different stages of the parasite's life cycle. Our research investigates the immunomodulatory effects of EVs released by the Y strain of T. cruzi trypomastigotes in a Chagas disease (CD) model. It also investigates the potential of EVs for developing new CD therapies and compares the effects of trypomastigotes with distinct virulence profiles. The protozoa parasite can survive in tissue culture-infected cells, it decreases virulence in mice. In our study, we successfully restored virulence in mice upon 20 consecutive passages. As a result, we performed a comparison study, comparing the impact of EVs released by non-virulent trypomastigotes maintained in vitro (P2) to virulent trypomastigotes maintained in vivo (P20). Our results suggest a new link between T. cruzi virulence and EV release. Infection with trypomastigotes P20 and P2 revealed higher parasitemia and tissue parasitism in P20-infected animals. EVs increase parasitism in the heart first, then the bladder, intestine, and lungs Pretreatment with EVs from the P20 strain exacerbated these effects compared to pre-treatment with P2 EVs or controls. In parallel, we investigated the dynamic cellular uptake of PHK26-labeled EVs using ImageStreams system microscopy. Both P2 and P20 EVs interacted immediately with human monocytes. Concurrently, we employed qRT-PCR to examine cytokine and chemokine expression in THP-1 cells upon incubation with P2 and P20 EVs. In conclusion, EVs released by virulent (P20) and non virulent (P2) parasites during their interactions with host cells and assess the impact on immune response communication, providing a detailed understanding of the complex interactions between protozoa parasite and host cells. This allows us to understand how virulence factors influence different stages of Chagas disease.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper